Laurion Capital Management’s Zymeworks ZYME Stock Holding History

Laurion Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-120,000	Closed	-$786K	–	731
2022 Q1	$786K	Buy	+120,000	New	+$1.07M	0.01%	266
2018 Q4	–	Sell	-12,032	Closed	-$189K	–	1475
2018 Q3	$189K	Sell	12,032 -97,043	-89%	-$1.39M	﹤0.01%	1057
2018 Q2	$1.61M	Buy	+109,075	New	+$1.69M	0.01%	654

Other funds holding ZYME

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Laurion Capital Management's ZYME Position: Q2 2022 in Review

Laurion Capital Management sold out of Zymeworks (ZYME) in Q2 2022, closing a stake of 120,000 shares — an estimated $786K sold.

Laurion Capital Management first reported a position in ZYME in Q2 2018 and held it in 3 quarters. The position peaked at $1.61M in Q2 2018. 113 funds tracked by Wall St. Rank hold ZYME as of Q2 2022.

Laurion Capital Management reported no remaining Zymeworks position as of Q2 2022 after selling out during the quarter.
Laurion Capital Management sold 120,000 Zymeworks shares in Q2 2022, an estimated $786K.
Laurion Capital Management first reported a position in Zymeworks in Q2 2018 and held it in 3 quarters.
Laurion Capital Management's Zymeworks position peaked at $1.61M in Q2 2018.
113 funds tracked by Wall St. Rank held Zymeworks as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.